Sanaby Health Acquisition I closed its IPO as well as the exercise of the over-allotment option in full by the underwriters, resulting in the sale of 17.25 million units at $10 each.
Sanaby Health intends to identify opportunities in the healthcare industry, with a focus on digital health, life science tools and services, and innovative therapeutics.
Cohen & Company Capital Markets advises the company.
BTIG was sole book-runner for the offering. I-Bankers Securities was co-manager. Read more.
